Who
Vandana Sriram
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Quanterix; SVP Finance & Corp. Controller, Azenta.
In numbers
- Trades disclosed
- 121
- Buys
- 1
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 29 Jul 2022
- Last trade
- 15 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —263 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $24579 at $3.10 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —514 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —263 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —514 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,056 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $477154 at $3.10 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —1,056 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $977315 at $3.10 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —263 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —514 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,056 at $0.00 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —263 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $24579 at $3.10 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —514 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $477154 at $3.10 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —1,056 | filing |
| 15 Jun 2026filed 23 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $977315 at $3.10 | filing |
| 15 May 2026filed 18 May 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —263 | filing |
| 15 May 2026filed 18 May 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $21779 at $2.75 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisQTRX · tickerreport.com · 15 Oct 2026ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchQTRX · prnewswire.com · 8 Oct 2026
0 headlines in the last 90 days name Vandana Sriram; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.